Quantum Biopharma (QNTM) Intangibles (2019 - 2026)

Quantum Biopharma's Intangibles history runs 8 years deep, the most recent figure standing at $4.4 million for Q1 2026.

• In Q1 2026, Intangibles fell 8.71% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $4.4 million (down 8.71% YoY), while the FY2025 annual figure was $4.5 million, down 8.53% from the prior year.
• Intangibles came in at $4.4 million for Q1 2026 at Quantum Biopharma, down from $4.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $15.4 million in Q1 2022 to a low of $4.4 million in Q1 2026.
• A 5-year average of $7.6 million and a median of $5.1 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles advanced 19.01% in 2022 and slumped 60.98% in 2023, its largest moves.
• Quantum Biopharma's Intangibles stood at $12.0 million in 2022, then sank by 54.64% to $5.5 million in 2023, then dropped by 9.66% to $4.9 million in 2024, then fell by 8.53% to $4.5 million in 2025, then declined by 2.3% to $4.4 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $4.4 million, $4.5 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison